Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
900 participants
OBSERVATIONAL
2007-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
PURPOSE: This clinical trial is studying blood samples in patients with breast cancer.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Tumor and Blood Samples From Women With Breast Cancer
NCT00897728
Proteomic Signature in Breast Cancer: Correlation With Tumor Response to Neo-adjuvant Chemotherapy
NCT00911911
Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer
NCT00463034
Blood Levels of Tumor Cells in Predicting Response in Patients Receiving First-Line Chemotherapy for Stage IV Breast Cancer
NCT00898014
A Study to Determine the Clinical Significance of Molecular Detection of Breast Cancer in the Blood of Stage IV Breast Cancer Patients
NCT00355316
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Identify constitutional gene variants associated with a change in response.
OUTLINE: Blood samples are collected periodically for analysis of genetic factors.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
laboratory biomarker analysis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Histologically confirmed breast carcinoma
* Received first-line chemotherapy (in neoadjuvant or metastatic setting) comprising anthracyclines and/or taxanes, including for a second primary cancer
* Patient agrees to conservative surgery
* Hormone receptor status not specified
PATIENT CHARACTERISTICS:
* Menopausal status not specified
* No contraindication for chemotherapy comprising anthracyclines and/or taxanes
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
* No prior adjuvant therapy
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Oscar Lambret
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jacques Bonneterre, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Centre Oscar Lambret
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Oscar Lambret
Lille, , France
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COL-GENEOM
Identifier Type: -
Identifier Source: secondary_id
COL-IDRCB-2007-A00908-45
Identifier Type: -
Identifier Source: secondary_id
COL-2007-08
Identifier Type: -
Identifier Source: secondary_id
INCA-RECF0635
Identifier Type: -
Identifier Source: secondary_id
CDR0000633531
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.